AzTrials
AzTrials

HealthyNCT03383250

Metabolomic Response to Meal Ingestion

A study testing Normal meal in people with Healthy, run by Hospital Universitari Vall d'Hebron Research Institute.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators have recently shown that postprandial sensations correlate with changes in circulating metabolites after a meal ingestion; however this phenomenon was demonstrated with a meal load up to the level of tolerance which involved an unpleasant fullness sensation. Read more about this study

Who is it for?
Ages 18 to 70 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Normal meal
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
No sites listed yet
Study dates
15 Nov 2014to 15 Oct 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • non obese

Who cannot join

  • history of gastrointestinal symptoms
  • prior obesity
  • use of medications
  • history of anosmia and ageusia
  • current dieting
  • alcohol abuse
  • psychological disorders
  • eating disorders

About this study

Official title: Factors to Determine the Responses to Meal Ingestion: Circulating Metabolites

The investigators have recently shown that postprandial sensations correlate with changes in circulating metabolites after a meal ingestion; however this phenomenon was demonstrated with a meal load up to the level of tolerance which involved an unpleasant fullness sensation. The aim of the present study is to determine changes in circulating metabolites of a satiating pleasurable meal. Healthy men (n = 32) will be evaluated after a 5 h fast. Perception measurements and blood samples will be taken before and 20 minutes after ingestion of a palatable probe meal (juice and warm ham and cheese sandwich, total 300 ml, 440 kcal). NMR spectroscopy will be performed to determine plasmatic Low Molecular Weight Metabolites (LMWM) and to characterize lipoprotein profiles (number of particles, lipid content and size of the main three lipoprotein classes (VLDL, LDL and HDL). Homeostatic (satiety, fullness) and hedonic sensations (digestive well-being, mood) will be measured by 10 cm analogical scales.

Conditions
Healthy
Being tested
Normal meal
Keywords
meal ingestion, postprandial sensations, circulating metabolites

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Normal mealDietary supplement

Study groups in NCT03383250
Study groupRoleWhat they receive
Meal ingestionExperimentalNot described
Receives: Dietary Supplement: Normal meal

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Metabolomic response in serum

    Measured: 30 min

Secondary outcomes (5)
  1. Change in digestive well-being measured after the test meal

    Change in average well-being measured by 10 score scales at the end of the test meal.

    Measured: 1 day

  2. Change in satiety measured after the test meal

    Change in average satiety measured by 10 score scales at the end of the test meal

    Measured: 1 day

  3. Change in fullness sensation measured after the test meal

    Change in average fullness measured by 10 score scales at the end of the test meal

    Measured: 1 day

  4. Change in abdominal discomfort/pain sensation measured after the test meal

    Change in average abdominal discomfort/pain measured by 10 score scales at the end of the test meal

    Measured: 1 day

  5. Change in mood measured after the test meal

    Change in average mood measured by 10 score scales at the end of the test meal.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2017
  2. Study start15 Nov 2014
  3. Primary completion30 Jun 2017
  4. Study completion15 Oct 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03383250
Sponsor's protocol ID
PR(AG)338/2016D
Status last verified
Dec 2017
First submitted
19 Dec 2017
Last updated
4 Jan 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Normal meal in people with Healthy, run by Hospital Universitari Vall d'Hebron Research Institute.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Metabolomic response in serum (time frame: 30 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in